Join
Live feed
·
PRReleasevia Quantisnow
InflaRx N.V. logo

InflaRx Reports Positive Phase 2a Data for INF904 in Hidradenitis Suppurative (HS) and Chronic Spontaneous Urticaria (CSU)

ByQuantisnow·Wall Street's wire, on your screen.
IFRX· InflaRx N.V.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track IFRX (InflaRx N.V.) and more on Quantisnow.